Ghoul
Member
It is a strong response even from 92. Perhaps @Raww was on TRT or cruise, or had residual AAS in his system at time of the 92 baseline. The same disproportionate anti-AAS induced lipid rise applies to injectables, but they don’t have anything close to oral’s level of cholesterol trashing capacity on the liver.no i calculated it from 92 but still thought it was a great response
Another possible explanation is he’s one of those who absorbs more dietary cholesterol than average, and ezetimibe, which directly counteracts that, has a bigger impact than usual. In some genetic outliers, eze alone can reduce LDL by 80%+.
Last edited:

